Synonym
CIM-0216; CIM 0216; CIM0216;
IUPAC/Chemical Name
3,4-Dihydro-N-(5-methyl-3-isoxazolyl)-a-phenyl-1(2H)-quinolineacetamide
InChi Key
KSEXDSJYVSEVGF-UHFFFAOYSA-N
InChi Code
InChI=1S/C21H21N3O2/c1-15-14-19(23-26-15)22-21(25)20(17-9-3-2-4-10-17)24-13-7-11-16-8-5-6-12-18(16)24/h2-6,8-10,12,14,20H,7,11,13H2,1H3,(H,22,23,25)
SMILES Code
O=C(NC1=NOC(C)=C1)C(C2=CC=CC=C2)N3CCCC4=C3C=CC=C4
Purity
>95% (or refer to the Certificate of Analysis)
Shipping Condition
Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage Condition
Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
Solubility
Soluble in DMSO
Shelf Life
>3 years if stored properly
Drug Formulation
This drug may be formulated in DMSO
Stock Solution Storage
0 - 4 C for short term (days to weeks), or -20 C for long term (months).
HS Tariff Code
2934.99.03.00
Preparing Stock Solutions
The following data is based on the
product
molecular weight
347.41
Batch specific molecular weights may vary
from batch to batch
due to the degree of hydration, which will
affect the solvent
volumes required to prepare stock solutions.
| Concentration / Solvent Volume / Mass |
1 mg |
5 mg |
10 mg |
| 1 mM |
1.15 mL |
5.76 mL |
11.51 mL |
| 5 mM |
0.23 mL |
1.15 mL |
2.3 mL |
| 10 mM |
0.12 mL |
0.58 mL |
1.15 mL |
| 50 mM |
0.02 mL |
0.12 mL |
0.23 mL |
1: Held K, Gruss F, Aloi VD, Janssens A, Ulens C, Voets T, Vriens J. Mutations in the voltage-sensing domain affect the alternative ion permeation pathway in the TRPM3 channel. J Physiol. 2018 Jun;596(12):2413-2432. doi: 10.1113/JP274124. Epub 2018 Apr 25. PubMed PMID: 29604058; PubMed Central PMCID: PMC6002228.
2: Badheka D, Yudin Y, Borbiro I, Hartle CM, Yazici A, Mirshahi T, Rohacs T. Inhibition of Transient Receptor Potential Melastatin 3 ion channels by G-protein βγ subunits. Elife. 2017 Aug 15;6. pii: e26147. doi: 10.7554/eLife.26147. PubMed PMID: 28829742; PubMed Central PMCID: PMC5593506.
3: Thiel G, Rubil S, Lesch A, Guethlein LA, Rössler OG. Transient receptor potential TRPM3 channels: Pharmacology, signaling, and biological functions. Pharmacol Res. 2017 Oct;124:92-99. doi: 10.1016/j.phrs.2017.07.014. Epub 2017 Jul 16. Review. PubMed PMID: 28720517.
4: Rubil S, Thiel G. Activation of gene transcription via CIM0216, a synthetic ligand of transient receptor potential melastatin-3 (TRPM3) channels. Channels (Austin). 2017 Jan 2;11(1):79-83. doi: 10.1080/19336950.2016.1207026. Epub 2016 Jun 29. PubMed PMID: 27356187; PubMed Central PMCID: PMC5279878.
5: Held K, Kichko T, De Clercq K, Klaassen H, Van Bree R, Vanherck JC, Marchand A, Reeh PW, Chaltin P, Voets T, Vriens J. Activation of TRPM3 by a potent synthetic ligand reveals a role in peptide release. Proc Natl Acad Sci U S A. 2015 Mar 17;112(11):E1363-72. doi: 10.1073/pnas.1419845112. Epub 2015 Mar 2. PubMed PMID: 25733887; PubMed Central PMCID: PMC4371942.
